229 related articles for article (PubMed ID: 8231835)
1. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
[TBL] [Abstract][Full Text] [Related]
2. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
[TBL] [Abstract][Full Text] [Related]
3. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?
Glueck CJ; Glueck HI; Mieczkowski L; Tracy T; Speirs J; Stroop D
Thromb Haemost; 1993 May; 69(5):460-5. PubMed ID: 8322268
[TBL] [Abstract][Full Text] [Related]
4. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.
Glueck CJ; Freiberg R; Glueck HI; Tracy T; Stroop D; Wang Y
Am J Hematol; 1995 Apr; 48(4):213-20. PubMed ID: 7717367
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
7. Hypofibrinolysis: a common, major cause of osteonecrosis.
Glueck CJ; Freiberg R; Glueck HI; Henderson C; Welch M; Tracy T; Stroop D; Hamer T; Sosa F; Levy M
Am J Hematol; 1994 Feb; 45(2):156-66. PubMed ID: 8141121
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a).
Szymanski LM; Durstine JL; Davis PG; Dowda M; Pate RR
Metabolism; 1996 Nov; 45(11):1427-33. PubMed ID: 8931650
[TBL] [Abstract][Full Text] [Related]
9. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
[TBL] [Abstract][Full Text] [Related]
10. Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activity.
Glueck CJ; Glueck HI; Hamer T; Speirs J; Tracy T; Stroop D
Am J Med Sci; 1994 May; 307(5):317-24. PubMed ID: 7909648
[TBL] [Abstract][Full Text] [Related]
11. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
12. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects].
Kobayashi Y; Fukuo Y; Shibuya T; Terashi A
Nihon Ronen Igakkai Zasshi; 1990 Sep; 27(5):578-83. PubMed ID: 2124638
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic and inflammatory processes in pleural effusions.
Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I
Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
[TBL] [Abstract][Full Text] [Related]
16. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
[TBL] [Abstract][Full Text] [Related]
17. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
Xiong X; Zhao S; Wang Z; Lo L; Huang Q
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
[TBL] [Abstract][Full Text] [Related]
19. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
20. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population.
Sundell IB; Nilsson TK; Hallmans G; Hellsten G; Dahlén GH
Atherosclerosis; 1989 Nov; 80(1):9-16. PubMed ID: 2532510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
